Literature on the entry of AMPK into nucleus

AMP-activated protein kinase (AMPK) is a key metabolic regulator that plays a critical role in maintaining cellular energy homeostasis. Recent studies have shown that AMPK can also enter the nucleus, where it regulates gene expression and other nuclear functions. Several mechanisms have been proposed for the nuclear entry of AMPK, including direct translocation, interaction with nuclear transport proteins, and regulation by post-translational modifications. Here we review the current literature on the mechanisms and functions of AMPK nuclear entry, and its implications for cellular metabolism and disease.

One proposed mechanism for AMPK nuclear entry is through direct translocation across the nuclear membrane. However, the nuclear membrane is a selective barrier that prevents the entry of most proteins larger than 40 kDa. Therefore, it is unlikely that AMPK, which has a molecular weight of over 200 kDa, can enter the nucleus through this mechanism. Instead, several studies have suggested that AMPK interacts with nuclear transport proteins, such as importins and exportins, to facilitate its nuclear entry. For example, AMPK has been shown to interact with importin alpha and beta, which are responsible for transporting proteins into the nucleus. This interaction is mediated by the NLS (nuclear localization sequence) motif in the AMPK alpha subunit. Similarly, AMPK has been shown to interact with exportin-1, which is responsible for exporting proteins out of the nucleus. This interaction is mediated by the NES (nuclear export sequence) motif in the AMPK gamma subunit. These interactions suggest that AMPK can enter the nucleus through a regulated transport mechanism.

Post-translational modifications of AMPK have also been shown to regulate its nuclear entry. For example, phosphorylation of the AMPK alpha subunit at threonine 172, which is required for its activation, has been shown to promote its nuclear entry. This phosphorylation is mediated by upstream kinases, such as LKB1 and CaMKK2, and is thought to enhance the interaction between AMPK and importins. Conversely, dephosphorylation of the alpha subunit by protein phosphatases, such as PP2A, has been shown to reduce the nuclear entry of AMPK. Other post-translational modifications, such as acetylation and methylation, have also been implicated in regulating the nuclear entry of AMPK.

The nuclear entry of AMPK has several implications for cellular metabolism and disease. AMPK has been shown to regulate the expression of genes involved in glucose and lipid metabolism, as well as cell cycle progression and apoptosis. Therefore, the nuclear entry of AMPK may play a role in regulating these processes. In addition, several studies have shown that the nuclear localization of AMPK is altered in certain disease states, such as cancer and diabetes. For example, AMPK has been shown to accumulate in the nucleus of cancer cells, where it may regulate the expression of genes involved in cell proliferation and survival. Similarly, in diabetic rats, AMPK has been shown to accumulate in the nucleus of liver cells, where it may regulate the expression of genes involved in glucose metabolism.

In conclusion, the nuclear entry of AMPK is a complex and regulated process that involves interactions with nuclear transport proteins and post-translational modifications. The nuclear localization of AMPK has several implications for cellular metabolism and disease, and further research is needed to fully understand its functions in the nucleus